buprenorphine hydrochloride and naloxone hydrochloride dihydrate (Avera McKennan Hospital)
Welcome to the PulseAid listing for the buprenorphine hydrochloride and naloxone hydrochloride dihydrate drug offered from Avera McKennan Hospital. This Opioid Antagonist [EPC],Opioid Antagonists [MoA],Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
| NON-PROPRIETARY NAME: | buprenorphine hydrochloride and naloxone hydrochloride dihydrate |
| SUBSTANCE NAME: | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA],Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA] |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-03-24 |
| END MARKETING DATE: | 0000-00-00 |
buprenorphine hydrochloride and naloxone hydrochloride dihydrate HUMAN PRESCRIPTION DRUG Details:
| Item Description | buprenorphine hydrochloride and naloxone hydrochloride dihydrate from Avera McKennan Hospital |
| LABELER NAME: | Avera McKennan Hospital |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 2; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2016-03-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69189-0591_4e8c19fd-ad5d-461b-adad-466da9e0452d |
| PRODUCT NDC: | 69189-0591 |
| APPLICATION NUMBER: | ANDA203326 |
Other BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE Pharmaceutical Manufacturers / Labelers:
